Neuregulin Receptor ErbB2 Localization at T-tubule in Cardiac and Skeletal Muscle
Departments of Anatomy and Cell Biology (HU,AO) and Biomedical Laboratory Sciences (FT), School of Health Sciences, Shinshu University, Nagano, Japan, and 3rd Department of Internal Medicine (AN) and Department of Anatomy (KK,TM), Shinshu University School of Medicine, Nagano, Japan
Correspondence to: Hideho Ueda, MD, PhD, Department of Anatomy and Cell Biology, School of Health Sciences, Shinshu University, Matsumoto, Nagano 390-8621, Japan. E-mail: hueda{at}gipac.shinshu-u.ac.jp
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
(J Histochem Cytochem 53:8791, 2005)
Key Words: ErbB2 neuregulin cardiac muscle skeletal muscle T-tubule
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In the present study, we clearly demonstrate that ErbB2 is localized at the T-tubule not only in the cardiac muscle but also in the skeletal muscle of adult mice.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Antibodies
Rabbit polyclonal ErbB2 (sc-284) antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA); mouse monoclonal caveolin-3 (610420) antibody was obtained from BD Biosciences (Lexington, KY). Mouse monoclonal ryanodine receptor (RyR; MA3-925), and mouse monoclonal dihydropyridine receptor (DHPR; MA3-920) antibodies were purchased from Affinity Bioreagents, Inc. (Golden, CO). Mouse monoclonal myosin slow-type heavy chain (MHC-S) was purchased from Ylem S.R.L (West Nightcott Dulverton, United Kingdom). Immunofluorescence antibodies were purchased from Molecular Probes Inc., (Eugene, OR) including Alexa 488 or 594 conjugated to streptavidin, goat anti-mouse Ig or goat anti-rabbit Ig.
Immunohistochemistry
Immunohistochemistry was performed as in our previous study (Ueda et al. 2004). Briefly, adult mice anesthetized with sodium pentobarbiturate were perfused with 4% paraformaldehyde. Subsequently, the quadriceps muscles were removed and immersed in the fixative overnight at 4C. After being rinsed in phosphate-buffered saline (PBS), they were immersed in 30% sucrose for cryoprotection overnight at 4C, embedded in optimal cutting temperature compound and sectioned at 10-µm thickness in a cryostat. Cryosections were treated with 1% Triton X-100 in PBS and 10% goat serum, incubated with primary (1:100) and secondary (1:500) antibodies, and observed with a confocal laser scanning microscope (LSM510, Carl Zeiss Japan Co.; Tokyo, Japan). For the control, we used PBS instead of primary antibodies following the procedure described above.
Immunoelectron Microscopy
Cryosections at 10-µm thickness fixed with 4% paraformaldehyde were treated with 1% Triton X-100 and 1% H2O2 in PBS for 30 min. Subsequently, the sections were incubated with 10% goat serum for 30 min and rabbit polyclonal ErbB2 antibody (1:100) overnight at 4C, followed by incubation with biotin-conjugated goat anti-rabbit Ig and streptavidin coupled with horseradish peroxidase using the Histofine Kit according to the manufacturer's protocol (Nichirei; Tokyo, Japan). After being rinsed in PBS, they were treated with metal-enhanced DAB substrate (Amersham Biosciences Corp.; Piscataway, NJ) and 1% osmium tetroxide for 30 min, dehydrated in a graded series of ethanol and acetone, and embedded in Epoxi resin by the inverted gelatin capsule method. Ultrathin sections at 70-nm thickness were counterstained with only uranyl acetate and were observed with a JEM-1200 electron microscope (Nihondenshi Co.; Tokyo, Japan).
Immunoblotting
Cardiac and quadriceps muscles were chopped into small pieces and homogenized in 10 mM N-(2-hydroxylethyl) piperazine-2'-2-ethanesulfonic acid (HEPES) buffer at pH 7.4, containing 150 mM NaCl, 1 mM EDTA, 1% IGEPAL-630, 1 mM PMSF, 1 µg/ml pepstatin, and 2 µg/ml aprotinin at 4C (10% w/v), respectively. The homogenates were centrifuged at 10,000 x g for 10 min at 4C and the supernatant used as the postnuclear fraction. Total protein concentrations were determined using the Lowry method. Thirty micrograms of each protein in the postnuclear fraction were resolved on 7% SDS-PAGE under reducing conditions with 5% 2-mercaptoethanol and electrotransferred to a nitrocellulose sheet for 30 min at 15 V. After blocking with 5% skim milk, the sheets were incubated with polyclonal ErbB2 antibody (1:500) overnight at 4C. They were then incubated with peroxidase conjugated to goat anti-rabbit Ig, and visualized using an electrochemiluminescence immunoblotting detecting system (Amersham Pharmacia Biotech Inc.; Buckinghamshire, United Kingdom).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
It has been widely accepted that ErbB2 overexpression in mammary carcinomas yields a poor prognosis (Slamon et al. 2001). Humanized mouse monoclonal antibody [trastuzumab (Hereceptin)] is an effective agent for the regulation of ErbB2 receptor activity in metastatic breast carcinoma, but it promotes the development of dilated cardiomyopathy in combination with anthracycline (Slamon et al. 2001
; Yarden and Sliwkowski 2001
). Conditional ErbB2 mutants survived to adulthood but developed severe dilated cardiomyopathy arising usually in the second month of age (Crone et al. 2002
; Ozcelik et al. 2002
). Ozcelik et al. (2002)
first demonstrated that ErbB2 was localized at the T-tubule in cardiac muscle as well as skeletal muscle using confocal microscopy, an observation that is supported by immunoelectron microscopy experiments in the present study. ErbB receptors are known as regulators of many signaling cascades, involving ras/mitogen-activated protein kinase, phosphatidylinositol-3 (PI-3) kinase/Akt, rho/rac, and phospholipid C (Yarden and Sliwkowski 2001
). Many studies have shown that PI-3/Akt kinases activate to produce NO through endothelial NO synthase (Albrecht et al. 2003
; Massion and Balligand 2003
; Mungrue et al. 2003
), and Lemmens et al. (2004)
recently reported that neuregulin-1 has a negative inotropic effect and activates endothelial NO synthase in isolated rabbit cardiomyocytes. Accordingly, it is likely that neuregulinErbB2 plays a physiological role in adult cardiac muscle at the T-tubule, probably through NO production.
It has been suggested that neuregulin-1, which is produced in the endocardium, signals in a paracrine manner to the ErbB2/ErbB4 receptor heteromers present in the juxtaposed myocardium during heart development (Meyer and Birchmeier 1995). Additionally, exogenous neuregulin-1 was shown to convert working cardiac muscle to specialized cardiac muscle between 8.5 and 10.5 days postcoitum (Rentschler et al. 2002
). Although we did not determine whether ErbB2 was found in specialized cardiac muscle in the adult, it was interesting that endocardial cells expressed ErbB2 (present study). Presently, we have no idea why the endocardial cell expresses ErbB2, but it should be borne in mind that specialized cardiac muscle has no T-tubule. There might be a distinct correlation between the adult and embryonic heart with regard to neuregulin signaling between endocardial cells and specialized cardiac muscle, because it is unlikely that the signaling is attributed to the development of the cardiac conduction system in adulthood. We favor the conclusion described by Crone et al. (2002)
that the role of ErbB2 in the adult heart is distinct from its role during embryogenesis.
On the other hand, where is ErbB2 localized, and how does it function in skeletal muscle? Altiok et al. (1995) reported that ErbB2 was concentrated at the NMJ, and Lin et al. (2000)
concluded that ErbB2-deficient mice died at birth because of abnormal NMJ development at the diaphragm. These studies indicate that ErbB2 is necessary for NMJ formation during embryogenesis. However, transgenic mice with inactivated ErbB2 produced by gene ablation have shown normal NMJ formation, although the acetylcholine receptor level was decreased (Leu et al. 2003
). In our present study, we could not find NMJ labeled with ErbB2. At present, we do not have a good explanation for the discrepancy between our findings and those of previous studies (Altiok et al. 1995
; Lin et al. 2000
), but the possibility that ErbB2 expression in NMJ might be reduced in adult skeletal muscle cannot be excluded. Andrechek et al. (2002)
reported that mice devoid of ErbB2 in skeletal muscle had proprioceptive defects caused by a lack of muscle spindle, and induced apoptosis in myoblasts upon differentiation to myofibers. Indeed, we were able to find muscle spindles labeled with ErbB2, but their labeling was not as strong as that of the T-tubule. This finding suggests that ErbB2 expression decreases in adult muscle spindles. Taken together, and as documented in cardiac muscle, these results indicate that it is probable that ErbB2 function in adult skeletal muscle is different from that in the embryo.
In conclusion, we have demonstrated that ErbB2 localizes at the T-tubule not only in cardiac muscle but also in skeletal muscle of adult mice. These findings support the hypothesis that neuregulinErbB2 signaling plays a role in the muscle contractionrelaxation mechanism. Further studies may shed light on a new therapeutic approach to cardiac and skeletal muscle diseases.
![]() |
Acknowledgments |
---|
![]() |
Footnotes |
---|
![]() |
Literature Cited |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H (2003) Protective role of endothelial nitric oxide synthase. J Pathol 199:817[CrossRef][Medline]
Altiok N, Bessereau JL, Changeux JP (1995) ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate. EMBO J 14:42584266[Abstract]
Andrechek ER, Hardy WR, Girgis-Gabardo AA, Perry RL, Butler R, Graham FL, Kahn RC, et al. (2002) ErbB2 is required for muscle spindle and myoblast cell survival. Mol Cell Biol 22:47144722
Crone SA, Zhao YY, Fan L, Gu Y, Minamisawa S, Liu Y, Peterson KL, et al. (2002) ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med 8:459465[CrossRef][Medline]
Erickson SL, O'Shea KS, Ghaboosi N, Loverro L, Frantz G, Bauer M, Lu LH, et al. (1997) ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice. Development 124:49995011
Garratt AN, Ozcelik C, Birchmeier C (2003) ErbB2 pathways in heart and neural diseases. Trends Cardiovasc Med 13:8086[CrossRef][Medline]
Kramer R, Bucay N, Kane DJ, Martin LE, Tarpley JE, Theill LE (1996) Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc Natl Acad Sci USA 93:48334838
Lee KF, Simon H, Chen H, Bates B, Hung MC, Hauser C (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378:394398[CrossRef][Medline]
Lemmens K, Fransen P, Sys SU, Brutsaert DL, De Keulenaer GW (2004) Neuregulin-1 induces a negative inotropic effect in cardiac muscle. Circulation 109:324326
Leu M, Bellmunt E, Schwander M, Farinas I, Brenner HR, Muller U (2003) Erbb2 regulates neuromuscular synapse formation and is essential for muscle spindle development. Development 130:22912301
Lin W, Sanchez HB, Deerinck T, Morris JK, Ellisman M, Lee KF (2000) Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc Natl Acad Sci USA 97:12991304
Liu X, Hwang H, Cao L, Buckland M, Cunningham A, Chen J, Chien KR, et al (1998) Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail. Proc Natl Acad Sci USA 95:1302413029
Massion PB, Balligand J-L (2003) Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J Physiol 546:6375
Meyer D, Birchmeier C (1995) Multiple essential functions of neuregulin in development. Nature 378:386390[CrossRef][Medline]
Mungrue IN, Bredt DS, Stewart DJ, Husain M (2003) From molecules to mammals: what's NOS got to do with it? Acta Physiol Scand 179:123135[CrossRef][Medline]
Ozcelik C, Erdmann B, Pilz B, Wettschureck N, Britsch S, Hubner N, Chien KR, et al (2002) Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc Natl Acad Sci USA 99:88808885
Rentschler S, Zander J, Meyers K, France D, Levine R, Porter G, Rivkees SA, et al (2002) Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc Natl Acad Sci USA 99:1046410469
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783792
Ueda H, Tezuka H, Nakamura A (2004) Nuclear envelope breakdown is a prominent feature in spinal motor neurons of wasted mice. Acta Histochem Cytochem 37:159162[CrossRef]
Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127137[CrossRef][Medline]